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In the United Kingdom, the incidence of
multidrug-resistant (MDR) Salmonella Typhi
isolates has increased from 1.5% in 1989 to 34% in
1995 (1). The most common MDR Vi-phage types
have been M1 and E1, isolated from patients who
recently returned from Southeast Asia or the
Indian subcontinent (1). Although the increasing
incidence of MDR isolates of Vi-phage types El
and M1 has been particularly noteworthy,
outbreaks caused by drug-sensitive strains of
these Vi-phage types have continued to be
identified. For example, all four patients in a July
1997 outbreak had recently traveled to the
Dominican Republic; the causative strain was drug
sensitive and belonged to Vi-phage type E1 (2).
Discrimination within phage type is desir-
able for studying the epidemiology of MDR
strains of S. Typhi and for determining their
phylogenetic relationships with established
drug-sensitive types. Insertion sequence 200
profiling can differentiate between drug-sensi-
tive and drug-resistant strains of Vi-phage types
M1 and E1 but is unsuitable for subdivision
within these phage types (3).
We used plasmid profile typing and pulsed-
field gel electrophoresis (PFGE) for the molecular
characterization and subdivision of isolates of S.
Typhi of Vi-phage types E1, M1, and untypable Vi
strain (UVS) from outbreaks and sporadic cases.
We selected a panel of 18 strains comprising the
type strains of S. Typhi Vi-phage types E1 and
M1, as well as drug-sensitive and drug-resistant
isolates of these phage types from patients
infected in several countries of the Indian
subcontinent. We also included UVS and Vi-
phage type E1 isolates from the 1997 epidemic in
Tajikistan and an isolate of Vi-phage type E1
from an infection acquired in the Dominican
Republic in 1997 (Table). The type strains of Vi-
phage types E1 and M1 were isolated in Russia
and Canada in 1918 (E1) and 1939 (M1), which
demonstrates the subsequent global dissemina-
tion of these phage types over a prolonged period.
All drug-sensitive isolates of Vi-phage types
E1 and M1 were plasmid-free, whereas MDR
isolates were characterized by a plasmid of
approximately 120 megadaltons (MDa). The two
UVS isolates also had a 120-MDa plasmid and an
additional plasmid of 80 MDa. Conjugation and
incompatibility testing showed that the 120-MDa
plasmids encoded resistance to ampicillin,
chloramphenicol, streptomycin, sulphonamides,
tetracyclines, and trimethoprim and belonged to
incompatibility group H1. In contrast, the 80-
MDa plasmids in the two UVS isolates from
Tajikistan did not code for drug resistance and
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For epidemiologic investigations, the primary subdivision of Salmonella Typhi is vi-
phage typing; 106 Vi-phage types are defined. For multidrug-resistant strains the most
common types have been M1 (Pakistan) and E1 (India, Pakistan, Bangladesh, and the
Arabian Gulf); a strain untypable with the Vi phages has been responsible for a major
epidemic in Tajikistan. Most often, isolates from the Indian subcontinent have been
resistant to ampicillin, chloramphenicol, streptomycin, sulfonamides, tetracyclines, and
trimethoprim; but in the 1997 Tajikistan outbreak, the epidemic strain was also resistant
to ciprofloxacin. For multidrug-resistant strains, subdivision within phage type can be
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grouping. In isolates of Vi-phage type E1 and
UVS with additional resistance to ciprofloxacin,
resistance to this antimicrobial was chromo-
somally encoded.
PFGE following digestion of genomic DNA
with Xba I showed 19 to 23 fragments per strain,
with 13 fragments common to each and 1 to 12
band differences between patterns. Several
differences were identified, both between and
within phage types (Figure 1). For Vi-phage type
E1, six pulsed-field profiles (PFPs) (S. Typhi PFP
Stp X1 through PFP Stp X6) and one subtype
(PFP Stp X2a) were identified and defined. For
PFPs Stp X1, X2, X5, and X6, subdivision was
based on the numbers of fragments (from 150 kb
to >500 kb) and for PFPs X3 and X4, subdivision
was based on the number and size of fragments in
the 20-kb to 50-kb range, with PFP X3 also
lacking a 300-kp band present in PFP X4. The
PFPs of the two UVS isolates from Tajikistan
were indistinguishable from PFP X2a. For Vi-
phage type M1, two PFP types (PFPs X7 to X8)
and one subtype (PFP X8a) were identified. PFPs
X7 and X8 were designated as separate types on
the basis of the numbers of fragments in the 250-
kb to 500-kb range. PFP X2a could be
distinguished from PFP X2, and PFP  X8a could
be distinguished from PFP X8 by the presence of
three additional fragments of approximately 50
kb, 30 kb, and 25 kb. As these three fragments
were observed in isolates of PFPs X2a, X3, X4, X5,
and X8a, all of which had incompatibility group
H1 plasmids but were not identified in isolates of
PFPs X1, X2, X6, X7, and X8 (none of which
possessed H1 plasmids), it is likely that these three
fragments are plasmid-derived. These plasmid-
containing derivatives of PFPs X2 and X8 have been
designated PFPs X2a and X8a, respectively.
A dendogram (Figure 2) analyzed by pairwise
fragment comparison using the Dice coefficient
and by data clustering using the unweighted pair
group arithmetic averaging method (UPGMA)
clearly illustrated the relationships described
above. The Dice coefficient values, excluding
plasmid DNA, were from 66.7% to 97.6%. The
PFPs of Vi-phage type E1 and UVS and Vi-phage
type M1 clustered as two distinct groups with the
branch-point for the E1 and UVS PFPs X1-X6
cluster at approximately 80.5% and the M1 PFPs
X7-X8 cluster at approximately 86%. Within Vi-
phage type E1, PFPs X1 and X6 (isolates from
Russia and the Dominican Republic) are distinct
from the closely related PFP X2-X5 cluster (the
Indian subcontinent and Tajikastan), which
Table. Drug-resistant and drug-sensitive isolates of Salmonella Typhi phage types E1, M1, and UVS
Laboratory
accession Phage Country  Year of  Mol wt of Pulsed-field
number type of origin isolation Antibiograma plasmid DNA profile
E1 E1 Russia 1918          $   -b X1
P3047990 E1 India 1993          $   - X2
P2967750 E1 India 1992 ACSSuTTm 120 X2a
P3639160 E1 Pakistan 1994 ACSSuTTm 120 X2a
P3640980 E1 Pakistan 1994 ACSSuTTm 120 X2a
P4632360 E1 Bangladesh 1997 ACSSuTTm 120 X2a
P4663970 E1 Bangladesh 1997 ACSSuTTm 120 X2a
P4405140 UVS Tajikistan 1997 ACSSuTTmCp 120    80 X2a
P4405200 UVS Tajikistan 1997 ACSSuTTmCp 120    80 X2a
P4466680 E1 India 1997 ACSSuTTm 120 X3
P2951290 E1 Bangladesh 1992 ACSSuTTm 120 X4
P3166750 E1 Bangladesh 1993 ACSSuTTm 120 X4
P4219910 E1 Pakistan 1997 ACSSuTTmCp 120 X4
P4405160 E1 Tajikistan 1997 ACSSuTTm 120 X5
P4543210 E1 Dominican Republic 1997          $   - X6
M1 M1 Canada 1939          $   - X7
P3112100 M1 Pakistan 1992          $   - X8
P3044890 M1 Pakistan 1992 ACSSuTTm 120 X8a
aA, ampicillin; C, chloramphenicol; S, streptomycin; Su, sulphonamides; T, tetracyclines; Tm, trimethoprim; Cp, ciprofloxacin;
$, drug-sensitive.
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suggests a recent evolutionary divergence in Asia
within this universally common phage type.
These results demonstrate that PFGE,
coupled with plasmid profile analysis, is a useful
method for discriminating MDR isolates of S.
Typhi Vi-phage type E1. The results also suggest
that isolates of Vi-phage type E1 with the X2a
pulsed-field profile have been derived within the
Indian subcontinent from a drug-sensitive strain
of Vi-phage type E1 already endemic in this area.
This drug-sensitive progenitor strain is genotypi-
cally distinct from the type strain of Vi-phage
type E1, isolated in Russia in 1918 and more
recently in the Dominican Republic. In turn,
isolates of Vi-phage type E1 of PFPs X3-X5 are
closely related to PFP X2 and could have been
derived from PFP X2 in the course of its recent
epidemic history. The two UVS isolates from
Tajikistan had a PFP indistinguishable from PFP
X2a but differed by plasmid profile and
Figure 1. Pulsed-field gel electrophoresis profiles of
Xba I-digested genomic DNA from drug-resistant and
drug-sensitive isolates of  Salmonella Typhi Vi-phage
types E1, M1, and UVS. Tracks 1-20 contained 1 and
20, lambda 48.5-kb ladder (Sigma); 2, M1 type strain
(S. Typhi PFP Stp  X7); 3, P3044890 (PFP X8a); 4,
P3112100 (PFP X8); 5, E1 type strain (PFP X1); 6,
P3640980 (PFP X2a); 7, P3639160 (PFP X2a); 8,
P2967750 (PFP X2a); 9, P4405140 (PFP X2a); 10,
P4405200 (PFP X2a); 11, P4632360 (PFP X2a); 12,
P4663970 (PFP X2a); 13, P3047990 (PFP X2); 14,
P4543210 (PFP X6); 15, P4466680 (PFPX3); 16, 3166750
(PFP X4); 17, P2951290 (PFP X4); 18, P4219910 (PFP
X4); and 19, P4405160 (PFP X5). PFGE conditions: 180V
(5.4 V/cm); 45h; Ramp, 0.5 - 45s.
Figure 2. Dendogram of Salmonella Typhi pulsed-field
profiles Stp X1 -X8a. Genetic similarity was calculated
by the Dice coefficient (S) and clustered by unweighted
pair group arithmetic averaging method.
antibiogram and by at least three bands from that
of the MDR Vi-phage type E1 isolate from
Tajikistan (PFP X5). This suggests that despite
the recent observation that MDR strains of Vi-
phage type E1 and UVS are in circulation in
Tajikistan (4), the epidemic ciprofloxacin-
resistant UVS strain is more likely to have
originated in the Indian subcontinent than in
Tajikistan. Likewise, the drug-sensitive and
drug-resistant isolates of Vi-phage type M1 from
Pakistan are genotypically distinct from the type
strain of Vi-phage type M1 isolated in Canada in
1939. Again, this suggests that MDR strains of
Vi-phage type M1 have been derived in Pakistan
from a drug-sensitive progenitor strain of Vi-
phage type M1 already endemic in that country.
A previous PFGE-based study of S. Typhi
from Southeast Asia demonstrated that multiple
genetic variants associated with sporadic cases
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present in that area (5). The study also
demonstrated considerable genetic diversity
between strains, suggesting considerable move-
ment of these strains within endemic-disease
regions. However, the study did not use Vi-phage
typing for the preliminary identification and
subdivision of isolates. In our study, we combined
Vi-phage typing with plasmid analysis and PFGE
to provide a method of subdividing MDR isolates
of Vi-phage types El and M1 endemic in India,
Pakistan, and Bangladesh; we also compared the
resulting patterns with those from historic
isolates and isolates from recent outbreaks of
MDR S. Typhi in Tajikistan. Although further
work is needed to establish the applicability of
combining phage typing with plasmid typing and
PFGE for studying the epidemiology of MDR S.
Typhi, our studies demonstrate that subdivision
within the most common phage types can be
achieved and may be useful both for investigating
outbreaks and for providing information about the
evolutionary history of MDR epidemic strains.
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